Ownership history in ROYCE & ASSOCIATES LP · 40 quarters on record
This page tracks every 13F SEC filing in which ROYCE & ASSOCIATES LP reported a position in NEOGENOMICS INC (NEO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 132,586 | -860,000 | -86.6% | 0.01% | $1.0M | $7.72 |
| 2025 Q2 | ADDED | 992,586 | +134,540 | +15.7% | 0.07% | $7.3M | $7.31 |
| 2025 Q1 | ADDED | 858,046 | +182,180 | +27.0% | 0.09% | $8.1M | $9.49 |
| 2024 Q4 | ADDED | 675,866 | +36,390 | +5.7% | 0.10% | $11.1M | $16.48 |
| 2024 Q3 | ADDED | 639,476 | +19,780 | +3.2% | 0.09% | $9.4M | $14.75 |
| 2024 Q2 | ADDED | 619,696 | +44,799 | +7.8% | 0.08% | $8.6M | $13.87 |
| 2024 Q1 | REDUCED | 574,897 | -16,545 | -2.8% | 0.08% | $9.0M | $15.72 |
| 2023 Q4 | REDUCED | 591,442 | -5,300 | -0.9% | 0.09% | $9.6M | $16.18 |
| 2023 Q3 | ADDED | 596,742 | +119,192 | +25.0% | 0.07% | $7.3M | $12.30 |
| 2023 Q2 | ADDED | 477,550 | +27,000 | +6.0% | 0.07% | $7.7M | $16.07 |
As of 2025 Q4 — sorted by position size